Current Grants


Current Grants Awarded to Faculty

  • Shanjana Awasthi, Ph.D.

    Title of Project: "Surfactant protein-A regions as TLR4-immunomodulators"

    • Sponsoring Agency: National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)
    • Time Period: 08/08/17 through 07/31/22

  • Vibhudutta Awasthi, Ph.D.

    Title of Project: "Immunokinetics of superhydrophili polymer-modified liposome encapsulated hemoglobin"

    • Sponsoring Agency: Oklahoma Center for the Advancement of Science and Technology (OCAST)
    • Time Period: 09/01/17 through 08/31/20

    Title of Project: "Pharmacotherapy of traumatic brain injury accompanied by hemorrhagic shock.""

    • Sponsoring Agency: Department of Defense (DoD)
    • Time Period: 09/30/17 through 09/29/20

  • Hariprasad Gali, Ph.D.

    Title of Project: "PET imaging agent for myocardial infarction"

    • Sponsoring Agency: National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)
    • Time Period: 01/02/2019 - 12/31/2019

  • Randle Gallucci, Ph.D.

    Title of Project: "The role of specific inflammatory mediators in keratinocyte function and wound healing."

    • Sponsoring Agency: Presbyterian Health Foundation
    • Time Period: 07/01/18 - 06/30/19

  • Lucila Garcia-Contreras, Ph.D.

    Title of Project: "Preclinical assessment of OHet72 as a new drug in the armamentarium against TB and MDR-TB"

    • Sponsoring Agency: Oklahoma Center for Respiratory and Infectious Diseases (OCRID)
    • Time Period: 07/01/19 - 06/30/2022

  • Anne Kasus-Jacobi, Ph.D.

    Title of Project: "Wound healing mechanisms modulated by novel antimicrobial peptides."

    • Sponsoring Agency: NIH/National Eye Institute
    • Time Period: 09/30/16 - 08/31/19

    Title of Project: "Novel peptide therapeutic for corneal wound healing and infections."

    • Sponsoring Agency: Presbyterian Health Foundation
    • Time Period: 02/01/2019 - 01/31/2020

  • Grant Skrepnek, Ph.D.

    Title of Project: "Drug Utilization Review (DUR) board contract."

    • Sponsoring Agency: Oklahoma Health Care Authority
    • Time Period: 07/01/19 - 06/30/20

    Title of Project: "Improving evidence-based antibiotic use for treatment of infections commonly seen in long term care."

    • Sponsoring Agency: Oklahoma State Dept. of Health
    • Time Period: 07/01/18 - 06/30/20

  • Motolani E. Ogunsanya, Ph.D.

    Title of Project: "Assessing the cutaneous lupus erythematosus quality of life (CLEQol) scale: Longitudinal change and clinical applicability."

    • Sponsoring Agency: Presbyterian Health Foundation (seed grant)
    • Time Period: 07/01/18 - 06/30/20

  • H. Anne Pereira, Ph.D.

    Title of Project: "IDeA Translational Resource Application - Oklahoma Shared Clinical and Translational Resources - James (PI)."

    • Sponsoring Agency: National Institutes of Health (NIH) - NIH2U54GM1034938-06
      • Role (Pereira) - 20% effort as project leader of subproject ID 6189 - Clinical and Translational Research Pilot Projects Program Core (The goal is to use these pilot funds to help foster clinical research throughout Oklahoma, as well as other IDeA states.
    • Time Period: 08/03/2018 - 05/30/2023

  • R. Chris Rathbun, Pharm.D.

    Title of Project: "HIV Drug Assistance Program (HDAP) to promote adherence."

    • Sponsoring Agency: Oklahoma State Department of Health
    • Time Period: 04/01/11 through 03/31/2020

  • Amanda Sharpe, Ph.D.

    Title of Project: "Effects of dietary restriction on age-related neurophysiological adaptations; from behavior to single dopaminergic neurons."

    • Sponsoring Agency: Oklahoma Medical Research Foundation
    • Time Period: 05/01/18 - 04/30/21

    Title of Project: "The role of arcuate nucleus in the interaction between time-restricted feeding and circadian rhythm"

    • Sponsoring Agency: Presbyterian Health Foundation
    • Time Period: 07/01/2019 - 06/30/2020

  • Kelly Standifer, Ph.D.

    Title of Project: "Post-traumatic stress disorder and co-morbid chronic pain: Evidence that TNF initiates a sequelae involving nocioceptin/orphanin FQ"

    • Sponsoring Agency: Oklahoma Center for the Advancement of Science and Technology (OCAST)
    • Time Period: 08/01/19 through 07/31/20

  • Wei Yue, Ph.D.

    Title of Project: "AFPE Pre-doctoral fellowship for Alex Crowe - Year 2"

    • Sponsoring Agency: American Foundation for Pharmaceutical Education (AFPE)
    • Time Period: 09/01/19 through 06/30/20